title: Consequences of a combined administration of different doses of aprotinin and autologous blood transfusions for coagulation and fluid replacement in cardiac surgery.
authors.affiliation: Department of Cardiovascular Surgery, Augsburg Medical Center, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Gschossmann
authors.forename: P
authors.initials: P
authors.lastname: Pracki
authors.forename: C
authors.initials: C
authors.lastname: Vicol
authors.forename: E
authors.initials: E
authors.lastname: Struck
mesh_terms: D007611:Aprotinin / Q000008:administration & dosage*; D001777:Blood Coagulation; D001804:Blood Transfusion, Autologous; D006348:Cardiac Surgical Procedures; D004311:Double-Blind Method; D005440:Fluid Therapy; D006452:Hemoglobinometry; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control; D010314:Partial Thromboplastin Time; D011183:Postoperative Complications / Q000517:prevention & control; D011517:Prothrombin Time
chemical_list: D007611:Aprotinin